Macrogen Europe appoints Dr Bongcho Kim as new CEO

pharmafile | April 27, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful career at Macrogen Inc in Seoul, South Korea.

He joined Macrogen Inc in 2013 as a general manager for next-generation sequencing overseas sales, before being promoted to director and later vice president. Most recently, Dr Kim served as the managing director for the company’s technology and innovation division. Dr Kim holds a PhD in Pathology from Seoul National University.

Macrogen Europe is a provider of genomic sequencing services, and has plans for future expansion, Dr Kim commented: “Being able to offer a complete solution for the latest applications will be an important driver for growth in the coming years.”

Related Content

No items found

Latest content